Showing results (1-10 of 80) with videos related to
Sort By:
Pageof 8
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|July 30, 2011
Deformable self-propelled domain in an excitable reaction-diffusion system in three dimensionsK Shitara, T Hiraiwa, T OhtaCancer Research|September 1, 1986
Generation of monoclonal antibodies against human lung squamous cell carcinoma and adenocarcinoma using mice rendered tolerant to normal human lungN Hanai, K Shitara, H YoshidaCancer Research|October 1, 1986
Distribution of a squamous cell lung carcinoma-associated antigen, KA-32, in human tissues and sera defined by monoclonal antibody KM-32N Hanai, K Shitara, H YoshidaAnticancer Research|May 1, 1993
Detection of a novel lung adenocarcinoma--associated serum antigen defined by two monoclonal antibodies, KM 432 and KM 227K Shitara, N Hanai, H YoshidaCancer Chemotherapy and Pharmacology|August 19, 2000
Recombinant antibodies against ganglioside expressed on tumor cellsN Hanai, K Nakamura, K ShitaraCancer Research|March 1, 1987
Distribution of lung adenocarcinoma-associated antigens in human tissues and sera defined by monoclonal antibodies KM-52 and KM-93K Shitara, N Hanai, H YoshidaAnnals of Oncology : Official Journal of the European Society for Medical Oncology|February 11, 2017
New agents on the horizon in gastric cancerF Lordick, K Shitara, Y Y JanjigianCancer Immunology, Immunotherapy : CII|August 14, 2001
Construction of humanized anti-ganglioside monoclonal antibodies with potent immune effector functionsK Nakamura, Y Tanaka, K Shitara, et al.Anticancer Research|November 1, 1993
Immunocytochemical study on internalization of anti-carbohydrate monoclonal antibodiesA Kusano, S Ohta, K Shitara, et al.Anticancer Research|July 1, 1989
Advantage of cocktail-use of two anti-tumor monoclonal antibodies, KM-93 and KM-231, in serum diagnosis of cancerK Shitara, N Hanai, A Furuya, et al.Pageof 8